Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Genetic and Haematological Modifiers of Disease Severity Among Patients With Sickle Cell Disease (SCD) in Kaduna State, Northern Nigeria

NCT05837871 is registered in ClinicalTrials.gov with Ahmadu Bello University Teaching Hospital as lead sponsor.

NCT NCT05837871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05837871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Genetic and Haematological Modifiers of Disease Severity Among Patients With Sickle Cell Disease (SCD) in Kaduna State, Northern Nigeria
Lead sponsor
Ahmadu Bello University Teaching Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2023
Completion date
June 1, 2025
Enrollment
400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease